piperacillin has been researched along with Diabetic Neuropathies in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bühler, S; Hornstein, OP; Richter, UG; Seidel, C | 1 |
Backonja, MM; Duan, RW; Nothaft, W; Rowbotham, MC; Thomas, J | 1 |
Awni, W; Dutta, S | 1 |
Awni, WM; Dutta, S; Hosmane, BS | 1 |
Arneric, SP; Bannon, AW; Campbell, JE; Decker, MW; Kim, DJ | 1 |
4 trial(s) available for piperacillin and Diabetic Neuropathies
Article | Year |
---|---|
Drug therapy of diabetic neuropathic foot ulcers: transvenous retrograde perfusion versus systemic regimen.
Topics: Aged; Dexamethasone; Diabetic Neuropathies; Drug Therapy, Combination; Foot Ulcer; Gentamicins; Heparin; Humans; Infusions, Intravenous; Lidocaine; Male; Middle Aged; Piperacillin; Pyrrolidines; Vasodilator Agents | 1991 |
A randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of ABT-594 in patients with diabetic peripheral neuropathic pain.
Topics: Aged; Analgesics, Non-Narcotic; Azetidines; Data Interpretation, Statistical; Diabetic Neuropathies; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Pain; Pain Measurement; Pyridines; Socioeconomic Factors; Treatment Outcome | 2009 |
Population pharmacokinetics of ABT-594 in subjects with diabetic peripheral neuropathic pain.
Topics: Adult; Age Factors; Analgesics; Azetidines; Creatinine; Diabetic Neuropathies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Likelihood Functions; Male; Models, Biological; Nonlinear Dynamics; Pyridines | 2012 |
Population analyses of efficacy and safety of ABT-594 in subjects with diabetic peripheral neuropathic pain.
Topics: Aged; Azetidines; Diabetes Mellitus; Diabetic Neuropathies; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Female; Headache; Humans; Male; Middle Aged; Neuralgia; Nonlinear Dynamics; Pyridines; Treatment Outcome | 2012 |
1 other study(ies) available for piperacillin and Diabetic Neuropathies
Article | Year |
---|---|
ABT-594, a novel cholinergic channel modulator, is efficacious in nerve ligation and diabetic neuropathy models of neuropathic pain.
Topics: Administration, Oral; Analgesics, Non-Narcotic; Animals; Azetidines; Cholinergic Antagonists; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperalgesia; Injections, Intraperitoneal; Ligation; Lumbosacral Region; Male; Morphine; Pain; Pyridines; Rats; Rats, Sprague-Dawley; Spinal Nerves; Time Factors | 1998 |